コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ecule-1 and neutrophil gelatinase-associated lipocalin).
2 ecule-1 and neutrophil gelatinase-associated lipocalin.
3 the same protein, which was identified as a lipocalin.
4 , junb, and neutrophil gelatinase-associated lipocalin.
5 tact PCs in tears are native ligands of tear lipocalin.
6 activation neutrophil gelatinase-associated lipocalin.
7 in response to allergenic and nonallergenic lipocalins.
8 s from house dust mites and cockroaches, and lipocalins.
9 days were categorized as secreted, including lipocalins.
10 lar pocket is similar among human and animal lipocalins.
13 e 3' clustering of rare codons, unlike human lipocalin-1 and 21 other widely expressed human tear gen
14 Mechanistically, LINC00305 interacted with lipocalin-1 interacting membrane receptor (LIMR), enhanc
15 g proteins-zinc-alpha2-glycoprotein (AZGP1), Lipocalin-1, Albumin, S100A7, S100A8 and S100A9-revealed
16 nferior for neutrophil gelatinase-associated lipocalin [14.7 mug/L (interquartile range 7.60-28.9) vs
18 usly secretion of the iron chelating protein lipocalin 2 (LCN2) and protons, which acidify the urine.
19 We have recently characterized the role of lipocalin 2 (Lcn2) as a new adipose-derived cytokine in
21 ough molecular and genetic analyses in mice, lipocalin 2 (LCN2) as an osteoblast-enriched, secreted p
27 how that a mutant form (K3Cys) of endogenous lipocalin 2 (LCN2) is filtered by the kidney but can byp
30 at tNLGs mediate a potent CRISPR knockout of Lipocalin 2 (Lcn2), a known breast cancer oncogene, in h
33 d the potential of cerebrospinal fluid (CSF) lipocalin 2 (LCN2), a secreted glycoprotein that has bee
35 ulating levels of the secreted glycoprotein, lipocalin 2 (Lcn2), an adipokine previously associated w
37 s-including kidney injury molecule-1 (Kim1), lipocalin 2 (Lcn2), and keratin 8 (Krt8)-and of several
38 However, Ent is bound by the host protein lipocalin 2 (Lcn2), preventing bacterial reuptake of afe
39 oprotection markers, including COX-2 itself, lipocalin 2 (LCN2), tissue inhibitor of metalloproteinas
45 osterone system (RAAS) activation, and serum lipocalin 2 and biomarkers of inflammation and cardiac s
51 8 signaling is required for the induction of lipocalin 2 secretion and iron sequestration in the sple
52 ory factors such as dietary iron and luminal lipocalin 2 should be taken into consideration for optim
54 that use catecholate-type siderophores, and lipocalin 2(-/-) mice are highly susceptible to infectio
55 rtened colons, and increased fecal levels of lipocalin 2), metabolic syndrome, and an inability to cl
56 ain Salmonella by promoting the induction of lipocalin 2, a host antimicrobial factor that inhibits b
57 s survival advantage is counter-regulated by lipocalin 2, a siderophore-binding host protein, which r
59 F9, IL-6, IL-19, CCL20, S100A7/A8/A9, DEFB4, lipocalin 2, and peptidase inhibitor 3 (p < 0.05), indic
61 bial protein siderocalin (SCN; also known as lipocalin 2, neutrophil gelatinase-associated lipocalin/
62 vercome iron restriction by the host protein lipocalin 2, which counteracts some siderophores, is ess
63 observed to be Dectin-1 and IL-22 dependent, lipocalin 2-deficient mice did not demonstrate impaired
67 8; CCL20/FCH, 8.36; PI3 [elafin]/FCH, 15.40; lipocalin 2/FCH, 6.94, human beta-defensin 2 [DEFB4A]/FC
68 helial-derived antimicrobial factors such as lipocalin-2 (LCN-2), a protein that specifically inhibit
69 n was associated with PAMP translocation and lipocalin-2 (LCN2) and chemokine (C-X-C motif) ligand 1
71 he antimicrobial siderophore-binding peptide Lipocalin-2 (Lcn2) are observed in inflammatory bowel di
72 and vehicle-treated DIO mice, we identified lipocalin-2 (Lcn2) as the gene most strongly upregulated
73 ich immunoassay (IA) was developed for human lipocalin-2 (LCN2) by functionalizing a KOH-treated poly
79 thelicidin antimicrobial protein (Camp), and lipocalin-2 (Lcn2) mRNA expression giving rise to cells
81 In the mouse, the osteoblast-derived hormone Lipocalin-2 (LCN2) suppresses food intake and acts as a
83 over 100 different cytokines, we found that Lipocalin-2 (LCN2) was the most substantially elevated p
84 SubAB induces expression of a novel form of Lipocalin-2 (LCN2), and describe its biological activity
85 levels of a specific inflammatory cytokine, lipocalin-2 (LCN2), were elevated in the plasmas of pati
88 an overcome metal ion starvation mediated by lipocalin-2 and calprotectin via alternative pathways, I
89 ression of antimicrobial proteins, including lipocalin-2 and calprotectin, which sequester essential
90 l ADC decrease and elevated plasma levels of lipocalin-2 and microRNA-150, was associated with a fata
91 ed by the immobilization of rabbit polygonal lipocalin-2 antibody on gold nanoparticles attached on g
92 m of MMA-associated kidney disease, identify lipocalin-2 as a biomarker of increased oxidative stress
97 ion of biomarkers, including K16, Ki67, CD3, lipocalin-2, CD11c, dendritic cell lysosome-associated m
99 bial protein siderocalin (SCN; also known as lipocalin-2, neutrophil gelatinase-associated lipocalin,
100 ys identified numerous biomarkers, including lipocalin-2, which was then used to monitor the response
101 trophils from mice genetically deficient for lipocalin 24p3 (24p3(-/-)) are defective in many neutrop
105 cretes siderophore-binding proteins, such as lipocalin 24p3, which limit siderophore-mediated iron im
108 an in vitro system we compared the effect of lipocalin allergens and nonallergenic homologues on huma
111 induces IL-10 expression by DCs treated with lipocalin allergens, attenuating the T(H)2 bias and indu
112 gen Can f 6, a member of a distinct class of lipocalin allergens, has very similar properties to Fel
113 , hLCN1 and hLCN2, and most important animal lipocalin allergens, such as Can f 1, Can f 2 and Can f
114 as major facilitator family transporters and lipocalins, also reflect the evolution of xenobiotic ada
115 ntration of neutrophil gelatinase-associated lipocalin, an established AKI biomarker, and the associa
116 utility of neutrophil gelatinase-associated lipocalin and creatinine, alone and in combination, for
119 ast-derived metabolic hormones (osteocalcin, lipocalin and sclerostin) and the clinical evidence that
120 Urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule 1 predicted
121 oth urinary neutrophil gelatinase-associated lipocalin and varying creatinine-based metrics of renal
122 ed transcripts with contigs with identity to lipocalins and acid tail proteins being the most represe
124 lasma NGAL (neutrophil gelatinase-associated lipocalin) and NT-proBNP (N-terminal pro-B-type natriure
125 ecule-1 and neutrophil gelatinase-associated lipocalin, and doses>/=0.005 mg/kg induced the early res
126 n C (Scyc), neutrophil gelatinase-associated lipocalin, and interleukin-18 in predicting early graft
128 Biomarkers, neutrophil gelatinase-associated lipocalin, and kidney injury molecule-1 were successfull
130 , histones, neutrophil gelatinase-associated lipocalin, and proteinase-3) were elevated in the blood
131 protein B1, neutrophil gelatinase-associated lipocalin, and S100B were higher in nonsurvivors than su
132 iostin, and neutrophil gelatinase-associated lipocalin; and a two-fold decrease in glycosylated clust
136 the formyl peptide receptor 3 in allergy to lipocalins are outstanding examples of research into the
141 of urinary neutrophil gelatinase-associated lipocalin best predicted the primary outcome when measur
151 hough the intact phospholipids bound to tear lipocalin corresponded precisely in mass and relative si
152 ntin [OPN], neutrophil gelatinase-associated lipocalin, cystatin C, trefoil factor 3, tissue inhibito
154 Differential expression of these I. ricinus lipocalins during feeding at distinct developmental stag
155 man retinol binding protein 4 (hRBP4) of the lipocalin family interacts with engineered hRBP4 binders
156 emonstrate the Plasmodium-tailored role of a lipocalin family member in hemozoin formation and unders
161 expression of Evokin (a lipid carrier of the lipocalin family), and in their ability to convert arach
162 Apolipoprotein D (apoD), a member of the lipocalin family, is a 29-kDa secreted glycoprotein that
164 beta-Lactoglobulin (BLG) is a member of lipocalin family, proteins with ability to bind small hy
165 mmalian siderophore-binding protein from the lipocalin family, specifically binds lanthanide and acti
169 d the prevalence of sensitization to the cat lipocalin Fel d 7 among 140 cat-sensitized Swedish patie
172 ures of Japanin, an 18 kDa immune-modulatory lipocalin from the Brown Ear Tick (Rhipicephalus appendi
174 m molecules neutrophil gelatinase-associated lipocalin, galectin-3, and lipocalin-like prostaglandin
175 Contrary to previously identified tomato lipocalin gene DQ222981, SlVRSLip was not regulated by c
178 ructure, polymorphism and functions of these lipocalins have been well described in the western Europ
179 robust predictions showing these I. ricinus lipocalins have the potential to bind monoamines similar
180 or proteins neutrophil gelatinase-associated lipocalin, hemopexin, and transferrin were increased in
181 , including neutrophil gelatinase-associated lipocalin, high-mobility group protein B1, intracellular
182 r similarity analysis of human and mammalian lipocalins highlights their function in innate immunity
183 rposition modeling were compared among human lipocalins, hLCN1 and hLCN2, and most important animal l
184 ker levels (neutrophil gelatinase-associated lipocalin, IL-18, and kidney injury molecule-1 measured
185 biomarkers: neutrophil gelatinase-associated lipocalin, IL-18, kidney injury molecule-1 (KIM-1), live
186 eak urinary neutrophil gelatinase-associated lipocalin, IL-18, KIM-1, liver fatty acid binding protei
192 Limb development membrane protein-1 (LMBR1)/lipocalin-interacting membrane receptor (LIMR)-type prot
196 rleukin 18, neutrophil gelatinase-associated lipocalin, kidney injury molecule 1, and liver fatty aci
197 cystatin C, neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and IL-18 in 528 pa
198 jury (urine neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, calbindin), followe
199 croalbumin, neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, IL-18, and liver-ty
200 rs (urinary neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, urinary liver-type
201 in (CLU), glycoproteins IIb/IIIa (ITGA2B/3), lipocalin (LCN2), lactoferrin (LTF), and the thrombopoet
203 and plasma neutrophil gelatinase-associated lipocalin level higher than 150 ng/mL enrolled between A
204 enrollment neutrophil gelatinase-associated lipocalin level was independently associated with surviv
205 enrollment neutrophil gelatinase-associated lipocalin level was the greatest (c-statistic, 0.78 [95%
208 iopsy and assayed for the urinary biomarkers lipocalin-like prostaglandin D synthase (L-PGDS), alpha(
209 tinase-associated lipocalin, galectin-3, and lipocalin-like prostaglandin D2 synthase with an MRA.
210 e give structural evidence that Bet v 1 is a lipocalin-like protein with a striking structural resemb
211 a parasite species secrete and internalize a lipocalin-like protein, PV5, to control heme crystalliza
213 NGAL/LCN2 (neutrophil gelatinase-associated lipocalin/lipocalin 2), a secreted glycoprotein that bin
214 initial and neutrophil gelatinase-associated lipocalin measured 3 hours after cardiopulmonary bypass
215 eas GFR and neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein-1, and tumor
216 n levels of neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein-1, and tumor
220 dney Injury Neutrophil Gelatinase-Associated Lipocalin [N-GAL] Evaluation of Symptomatic Heart Failur
221 , including neutrophil gelatinase-associated lipocalin (NGAL) and podocalyxin, concomitant with upreg
222 (CysC) and neutrophil gelatinase-associated lipocalin (NGAL) can predict development of renal dysfun
225 ich encodes neutrophil gelatinase-associated lipocalin (NGAL) had the highest fold increase (~60).
226 Urinary neutrophil gelatinase-associated lipocalin (NGAL) has emerged an early marker protein, pr
227 tic role of neutrophil gelatinase-associated lipocalin (NGAL) in a large population of patients with
231 etection of neutrophil gelatinase-associated lipocalin (NGAL) is developed by the immobilization of r
232 ion between neutrophil gelatinase-associated lipocalin (NGAL) levels and cardiovascular and all-cause
234 el of urine neutrophil gelatinase-associated lipocalin (NGAL) was lower (P = 0.031) in the treated gr
235 MMP-9, and neutrophil gelatinase-associated lipocalin (NGAL) were found in diseased groups compared
236 biotin, and neutrophil gelatinase-associated lipocalin (NGAL) were the most robust markers but were n
237 ipocalin-2, neutrophil gelatinase-associated lipocalin (NGAL)), which is expressed in the distal neph
238 e of plasma neutrophil gelatinase-associated lipocalin (NGAL), a novel marker of renal tubular damage
239 asmin (CP), neutrophil gelatinase-associated lipocalin (NGAL), and monocyte chemotactic protein 1 (MC
240 biomarker, neutrophil gelatinase associated lipocalin (NGAL), combined with contemporary biomarkers
241 values for neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), kidney injury
242 d levels of neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1) and e
244 croalbumin, neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), IL-1
245 , including neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), live
246 in (IL)-18, neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1, serum creati
247 Urinary neutrophil gelatinase-associated lipocalin (NGAL), monomeric NGAL (mNGAL), interleukin-18
248 etection of neutrophil gelatinase-associated lipocalin (NGAL), which is a new diagnostic marker of ac
250 and plasma neutrophil gelatinase-associated lipocalin (NGAL); each measurement was on the day of AKI
252 [KIM-1] and neutrophil gelatinase-associated lipocalin [NGAL]) and oxidative stress (8-hydroxy-2'-deo
253 Lcn2; 24p3; neutrophil gelatinase-associated lipocalin [NGAL]) is an antimicrobial host defense facto
254 , KIM-1 and neutrophil gelatinase-associated lipocalin, NGAL), kidney growth, and glomerulosclerosis,
257 o more than three animal-derived components--lipocalin (nMus m 1, rEqu c 1, Fel d 4, rCan f 1, 2), ka
262 GDS) siRNA and its inhibitor HQL-79, but not lipocalin PGDS (L-PGDS) siRNA and its inhibitor AT-56, s
263 mokine, and CCL26/eotaxin-3), T(H)17/T(H)22 (lipocalins, PI3/elafin, CCL20, S100A7/S100A8/S100A9, and
264 gamma2 were found to have elevated levels of Lipocalin prostaglandin D synthase (L-PGDS) expression i
265 In this study, we define a new role for lipocalin prostaglandin D synthase (L-PGDS) in the contr
267 h levels of neutrophil gelatinase-associated lipocalin representing acute tubular injury (corrected R
271 surface and to test the hypothesis that tear lipocalin retrieves lipids from the eyes of normal and d
273 employed in this study characterized unique lipocalins that play a role in tick blood-feeding and tr
274 es the three I. ricinus lipocalins with tick lipocalins that sequester monoamines, leukotrienes and f
278 IL)-18, and neutrophil gelatinase-associated lipocalin to predict PNF and DGF in 335 DCD kidneys pres
279 IL-18, and neutrophil gelatinase-associated lipocalin to predict viability of DCD kidneys varies fro
281 We hypothesize that binding of allergenic lipocalins to FPR3 might be a mechanism for induction of
282 milies (EF-hand, Tropomyosin, CAP, Profilin, Lipocalin, Trypsin-like serine protease, Cupin, BetV1, E
283 Renal vein neutrophil gelatinase-associated lipocalin, tumor necrosis factor-alpha, monocyte chemoat
284 secrete PGD2 in proinflammatory conditions, Lipocalin-type prostaglandin D synthase (L-PGDS) express
285 d rise in COX (cyclooxygenase)-2 and L-PGDS (lipocalin-type prostaglandin D synthase) expression, whi
287 t retinaldehyde dehydrogenase 2 (RALDH2) and lipocalin-type prostaglandin D2 synthase (LPGDS), which,
290 her urinary neutrophil gelatinase-associated lipocalin (uNGAL) can accurately predict persistent AKI,
291 el of urine neutrophil gelatinase-associated lipocalin (uNGAL) for diagnosing AKI and its prognostic
292 rker (urine neutrophil gelatinase-associated lipocalin [uNGAL]), forming a composite biomarker for pr
293 0.05), and neutrophil gelatinase-associated lipocalin urine protein (55.6 +/- 21.3 mug/mL versus 2.7
295 Urinary neutrophil gelatinase-associated lipocalin was measured at baseline and again less than 1
296 but urinary neutrophil gelatinase-associated lipocalin was most useful (81% specificity, 68% sensitiv
299 ing urinary neutrophil gelatinase-associated lipocalin with a novel creatinine-based metric, both ava
300 ng 803 sequences places the three I. ricinus lipocalins with tick lipocalins that sequester monoamine